belzutifan
Showing 1 - 13 of 13
Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)
Recruiting
- Renal Cell Carcinoma
- Belzutifan
- Palbociclib
-
Macquarie University, New South Wales, Australia
- +1 more
Aug 15, 2022
Carcinoma, Renal Cell Trial in United States (Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Belzutifan
-
Boston, Massachusetts
- +3 more
Jan 27, 2023
Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)
Active, not recruiting
- Advanced Solid Tumors
- +15 more
- Belzutifan
- (no location specified)
Sep 16, 2022
Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Beijing, Beijing, China
- +16 more
Jun 2, 2023
VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)
Active, not recruiting
- VHL - Von Hippel-Lindau Syndrome
- +5 more
- Belzutifan
-
Bethesda, Maryland
- +10 more
Aug 16, 2022
Carcinoma, Hepatocellular, Colorectal Tumors, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Pembrolizumab, Belzutifan,
Recruiting
- Carcinoma, Hepatocellular
- +5 more
- Pembrolizumab
- +2 more
-
Duarte, California
- +39 more
Jul 29, 2022
Healthy Trial in West Bend (Belzutifan)
Completed
- Healthy
- Belzutifan
-
West Bend, WisconsinSpaulding Clinical
Nov 5, 2020
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)
Recruiting
- Pheochromocytoma/Paraganglioma
- +2 more
- Belzutifan
-
Los Angeles, California
- +58 more
Jan 27, 2023
Carcinoma, Renal Cell Trial in Worldwide (Belzutifan, Lenvatinib, Cabozantinib)
Recruiting
- Carcinoma, Renal Cell
- Belzutifan
- +2 more
-
Chandler, Arizona
- +176 more
Jan 19, 2023
Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)
Recruiting
- Clear Cell Renal Cell Carcinoma
- Belzutifan
- +2 more
-
Duarte, California
- +250 more
Jan 27, 2023
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Birmingham, Alabama
- +229 more
Aug 11, 2022
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +5 more
-
New Haven, Connecticut
- +38 more
Jan 25, 2023
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +5 more
-
New Haven, Connecticut
- +37 more
Jan 25, 2023